There have been significant evidence-based literature updates regarding the management of acute ischemic stroke (AIS) in adult patients; these are discussed in a 2018 guideline update.
This drug class confers benefits in diabetic patients with heart failure, CV disease, and renal disease, but it is also associated with major adverse events.
While these products are generally safe when used according to labeling, pharmacists must be familiar with available evidence in order to help patients safely self-medicate.
Scientists from the University of Eastern Finland have identified alterations occurring in the human brain that signal the early stages of this common neurogenerative disease.
According to the CDC’s Behavioral Risk Factor Surveillance System 2013, nearly 71% of adults with atherosclerotic cardiovascular disease use aspirin regularly.